Nutraceutical Therapy Aims to Halt Cancer Spread medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
Collaborating with a nutraceutical company, Tata Memorial Centre aims to commercialise chromatin-degrading agents, expected for release in June or July. This development holds promise in mitigating treatment-related toxicity, as demonstrated in human trials across various cancers.
Noida (Uttar Pradesh) [India], January 4 (ANI/PRNewswire): Curadev Pharma has created a Clinical Advisory Group (CAG) comprising eminent oncologists to provide guidance in the design and execution of immune-oncology clinical trials with CRD3874, its lead non-nucleoside, allosteric small molecule STING agonist